Exact Mass: 293.1739328

Exact Mass Matches: 293.1739328

Found 72 metabolites which its exact mass value is equals to given mass value 293.1739328, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Anastrozole

alpha,alpha,Alpha,alpha-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

C17H19N5 (293.1640374)


Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer. It decreases the amount of estrogens that the body makes. Anastrozole belongs in the class of drugs known as aromatase inhibitors. It inhibits the enzyme aromatase, which is responsible for converting androgens (produced by women in the adrenal glands) to estrogens. CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7616; ORIGINAL_PRECURSOR_SCAN_NO 7613 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7651; ORIGINAL_PRECURSOR_SCAN_NO 7649 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7606; ORIGINAL_PRECURSOR_SCAN_NO 7604 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7609; ORIGINAL_PRECURSOR_SCAN_NO 7607 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7592; ORIGINAL_PRECURSOR_SCAN_NO 7590 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7638; ORIGINAL_PRECURSOR_SCAN_NO 7636 L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist CONFIDENCE standard compound; INTERNAL_ID 2750 CONFIDENCE standard compound; INTERNAL_ID 8532 D000970 - Antineoplastic Agents

   

Phenylalanyllysine

(2S)-6-Amino-2-{[(2S)-2-amino-3-phenylpropanoyl]amino}hexanoic acid

C15H23N3O3 (293.1739328)


Phenylalanyllysine is a dipeptide composed of phenylalanine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Lysylphenylalanine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanoic acid

C15H23N3O3 (293.1739328)


Lysylphenylalanine is a dipeptide composed of lysine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

E-10-Hydroxyamitriptyline

(2E)-2-[3-(dimethylamino)propylidene]tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

C20H23NO (293.1779548)


E-10-Hydroxyamitriptyline is only found in individuals that have used or taken Amitriptyline. E-10-Hydroxyamitriptyline is a metabolite of Amitriptyline. E-10-hydroxyamitriptyline belongs to the family of Dibenzocycloheptenes. These are compounds containing a dibenzocycloheptene moiety, which consists of two benzene connected by a cycloheptene ring.

   

N-Acetyl-3-hydroxyprocainamide

N-[2-(diethylamino)ethyl]-3-hydroxy-4-[(1-hydroxyethylidene)amino]benzene-1-carboximidic acid

C15H23N3O3 (293.1739328)


N-Acetyl-3-hydroxyprocainamide is a metabolite of procainamide. Procainamide is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias, classified by the Vaughan Williams classification system as class Ia. (Wikipedia)

   

Quifenadine

{1-azabicyclo[2.2.2]octan-2-yl}diphenylmethanol

C20H23NO (293.1779548)


Quifenadine is a second-generation H1-antihistamine.

   

(Z)-10-Hydroxyamitriptyline

2-[3-(dimethylamino)propylidene]tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

C20H23NO (293.1779548)


   

[1,1'-Biphenyl]-4-carbonitrile, 4'-(heptyloxy)-

[1,1-Biphenyl]-4-carbonitrile, 4-(heptyloxy)-

C20H23NO (293.1779548)


   

Amitriptylinoxide

N,N-dimethyl-3-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propanamine oxide

C20H23NO (293.1779548)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Levoprotiline

1-(methylamino)-3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propan-2-ol

C20H23NO (293.1779548)


   

Lysyl-Phenylalanine

2-[(2,6-diamino-1-hydroxyhexylidene)amino]-3-phenylpropanoic acid

C15H23N3O3 (293.1739328)


   

Anastrozole

Anastrozole

C17H19N5 (293.1640374)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

   

3,4,5,6-tetradehydrogeissoschizol

3,4,5,6-tetradehydrogeissoschizol

[C19H21N2O]+ (293.1653796)


   

Levoprtiline

Hydroxymaprotiline

C20H23NO (293.1779548)


   

3-Hydroxymaprotiline

3-Hydroxymaprotiline

C20H23NO (293.1779548)


   

2-Hydroxymaprotiline

2-Hydroxymaprotiline

C20H23NO (293.1779548)


   

Cyclic dinorpropoxyphene

Cyclic dinorpropoxyphene

C20H23NO (293.1779548)


   
   
   

5-Hepten-3-yn-1-ol, 2,2-dimethyl-7-[(1-naphthalenylmethyl)amino]-, (E)-

5-Hepten-3-yn-1-ol, 2,2-dimethyl-7-[(1-naphthalenylmethyl)amino]-, (E)-

C20H23NO (293.1779548)


   

CAY10398

4-(dimethylamino)-N-[6-(hydroxyamino)-6-oxohexyl]-benzamide

C15H23N3O3 (293.1739328)


   

Lys-phe

6-amino-2-(2-amino-3-phenylpropanamido)hexanoic acid

C15H23N3O3 (293.1739328)


A dipeptide formed from L-lysine and L-phenylalanine residues.

   

Phe-lys

2-(2,6-diaminohexanamido)-3-phenylpropanoic acid

C15H23N3O3 (293.1739328)


   

10-Hydroxyamitriptyline

10-Hydroxyamitriptyline

C20H23NO (293.1779548)


   

Ethyl [3-(triethoxysilyl)propyl]carbamate

Ethyl [3-(triethoxysilyl)propyl]carbamate

C12H27NO5Si (293.1658412)


   
   

(E)-10-Hydroxyamitriptyline

amitriptyline metabolite (+/-)-

C20H23NO (293.1779548)


   

TERT-BUTYL 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE-1-CARBOXYLATE

TERT-BUTYL 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE-1-CARBOXYLATE

C15H24BNO4 (293.1798294)


   
   

2-(AMINOMETHYL)-18-CROWN-6

2-(AMINOMETHYL)-18-CROWN-6

C13H27NO6 (293.1838282)


   

Phosphonic acid,[(diethylamino)carbonyl]-, dibutyl ester (9CI)

Phosphonic acid,[(diethylamino)carbonyl]-, dibutyl ester (9CI)

C13H28NO4P (293.1755858)


   

1-BOC-pyrrole-2-boronic acid, pinacol ester

1-BOC-pyrrole-2-boronic acid, pinacol ester

C15H24BNO4 (293.1798294)


   

N-BOC-3-(4-FLUOROBENZYL)PIPERIDINE

N-BOC-3-(4-FLUOROBENZYL)PIPERIDINE

C17H24FNO2 (293.1790976)


   

1,2-diphenyl-3-(1-piperidyl)propan-1-one

1,2-diphenyl-3-(1-piperidyl)propan-1-one

C20H23NO (293.1779548)


   
   

1-(1-benzylpiperidin-4-yl)-2-phenylethanone

1-(1-benzylpiperidin-4-yl)-2-phenylethanone

C20H23NO (293.1779548)


   

α,α-Bis[2-(diMethylaMino)ethyl]-

α,α-Bis[2-(diMethylaMino)ethyl]-

C16H24ClN3 (293.1658654)


   

ABT-724

2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-benzimidazole

C17H19N5 (293.1640374)


   

1-[1-[(4-Chlorophenyl)Methyl]-4-piperidinyl] piperazine

1-[1-[(4-Chlorophenyl)Methyl]-4-piperidinyl] piperazine

C16H24ClN3 (293.1658654)


   

Isobutyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate

Isobutyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate

C15H24BNO4 (293.1798294)


   

5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]cyclohepten-5-ol

5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]cyclohepten-5-ol

C20H23NO (293.1779548)


   

4-(Dibenzylamino)cyclohexanone

4-(Dibenzylamino)cyclohexanone

C20H23NO (293.1779548)


   

N-(4-Methylbenzoyl)-4-Benzylpiperidine

N-(4-Methylbenzoyl)-4-Benzylpiperidine

C20H23NO (293.1779548)


   

2-Quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-beta,beta-dimethyl-6-nitro-

2-Quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-beta,beta-dimethyl-6-nitro-

C15H23N3O3 (293.1739328)


   
   

(Z)-10-Hydroxyamitriptyline

(Z)-10-Hydroxyamitriptyline

C20H23NO (293.1779548)


   

alpha,alpha-Diphenyl-2-quinuclidinemethanol

alpha,alpha-Diphenyl-2-quinuclidinemethanol

C20H23NO (293.1779548)


   

1-[(4-Methylphenyl)methyl]-4-(1-pyrrolidinyl)pyrazolo[3,4-d]pyrimidine

1-[(4-Methylphenyl)methyl]-4-(1-pyrrolidinyl)pyrazolo[3,4-d]pyrimidine

C17H19N5 (293.1640374)


   

Quifenadine

Quifenadine

C20H23NO (293.1779548)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Amitriptylinoxide

Amitriptylinoxide

C20H23NO (293.1779548)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Levoprotiline

1-(methylamino)-3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propan-2-ol

C20H23NO (293.1779548)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

7-Ethyl-2-methylundecan-4-yl sulfate

7-Ethyl-2-methylundecan-4-yl sulfate

C14H29O4S- (293.17864540000005)


   

2-[4-(tert-butyl)phenoxy]-N-{[(dimethylamino)carbonyl]oxy}ethanimidamide

2-[4-(tert-butyl)phenoxy]-N-{[(dimethylamino)carbonyl]oxy}ethanimidamide

C15H23N3O3 (293.1739328)


   

3-(1-Benzylpiperidin-4-yl)triazolo[4,5-b]pyridine

3-(1-Benzylpiperidin-4-yl)triazolo[4,5-b]pyridine

C17H19N5 (293.1640374)


   

3-cyclopentyl-N-(2-phenylphenyl)propanamide

3-cyclopentyl-N-(2-phenylphenyl)propanamide

C20H23NO (293.1779548)


   

3-cyclohexyl-N-(1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)propanamide

3-cyclohexyl-N-(1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)propanamide

C15H23N3O3 (293.1739328)


   

N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739328)


   

N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739328)


   

N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739328)


   

N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739328)


   

N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739328)


   

N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739328)


   

2-[(3E)-3-ethylidene-1,2,4,12-tetrahydroindolo[2,3-a]quinolizin-5-ium-2-yl]ethanol

2-[(3E)-3-ethylidene-1,2,4,12-tetrahydroindolo[2,3-a]quinolizin-5-ium-2-yl]ethanol

C19H21N2O+ (293.1653796)


   

N(2)-[(R)-2-amino-2-phenylacetyl]-N-butyl-L-serinamide

N(2)-[(R)-2-amino-2-phenylacetyl]-N-butyl-L-serinamide

C15H23N3O3 (293.1739328)


   

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-alaninamide

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-alaninamide

C15H23N3O3 (293.1739328)


   
   

N-Acetyl-3-hydroxyprocainamide

N-Acetyl-3-hydroxyprocainamide

C15H23N3O3 (293.1739328)


   
   

tetradecyl sulfate

tetradecyl sulfate

C14H29O4S (293.17864540000005)


An organosulfate oxoanion that is the conjugate base of tetradecyl sulfonic acid, obtained by deprotonation of the O-sulfo group.

   
   

(2s)-6-amino-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}hexanoic acid

(2s)-6-amino-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}hexanoic acid

C15H23N3O3 (293.1739328)


   

6-amino-2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]hexanoic acid

6-amino-2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]hexanoic acid

C15H23N3O3 (293.1739328)